Syndax Pharmaceuticals Inc (SNDX) stock
SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.72−0.41 (-4.49%)
Close on Nov 20, 2026Market cap $778.67MP/E –Yield –
Syndax Pharmaceuticals gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Syndax Pharmaceuticals
Syndax Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?